Table 1.
Strain1 | Other strain designations | Source2 | Depositor | ST3 | Allelic profile | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
(Country, year of isolation) | atpD | gltB | gyrB | recA | lepA | phaC | trpB | ||||
LMG 28154T | VC11777T, CCUG 65685T | CF (Canada, 2003) | Current study | 813 | 337 | 391 | 583 | 355 | 407 | 311 | 393 |
R-20802 | VC12093 | CF (Canada, 2003) | Current study | 813 | 337 | 391 | 583 | 355 | 407 | 311 | 393 |
R-50762 | VC15152 | CF (Canada, 2009) | Current study | 813 | 337 | 391 | 583 | 355 | 407 | 311 | 393 |
LMG 28155 | 848157/5638 | CF (Germany, 2008) | L. Sedlacek | 815 | 338 | 392 | 584 | 356 | 408 | 311 | 394 |
TSV85 | Water (Australia, 2010) | Current study | 1295 | 404 | 564 | 848 | 481 | 524 | 311 | 524 | |
1LMG, BCCM/LMG Bacteria Collection, Laboratory of Microbiology, Ghent University, Ghent, Belgium; CCUG, Culture Collection University of Gothenburg, Department of Clinical Bacteriology, Sahlgrenska University Hospital, Gothenburg, Sweden.
2CF, isolated from a cystic fibrosis patient.
3Based on the B. cepacia complex scheme (https://pubmlst.org/bcc/).